Gemue puts automation inside
Pneumatic aseptic valves offer reduced installation costs and minimise faults
In the past, users needed three products to establish a functional unit – a valve, a solenoid and a switchbox, which had to be assembled using valve-specific mounting kits. Valve, measurement and control system company Gemue says the 651 provides a complete solution. It requires little mechanical installation and is ready for operation within just a few minutes thanks to the SpeedAP function. An analogue travel sensor continuously detects the valve position and the data is evaluated via a microprocessor.
The Gemue 651 is available as an open/close valve or with integrated positioner as a control valve in the nominal sizes DN 4–25. The maximum permissible operating pressure is 10 bar with EPDM diaphragms and 6 bar with PTFE diaphragms. The maximum permissible operating temperature during sterilisation is 150°C. The valve is CIP/SIP capable. Its compact design makes it ideally suitable for use where space is at a premium, for example within valve batteries and as a component of valve blocks in multi-port design. The pneumatic actuator section of the housing is made from stainless steel, while the automation module located above is made from PP (polypropylene).
Gemue says the essential advantages for the customer are: lower price; reduced installation costs; and reduced operating costs.
The valve is GMP-compatible, minimises potential faults such as leakages, connection and mounting errors as a result of integration and offers simplified logistics and materials management because there is now only one article number for the complete valve.
You may also like
Trending Articles
You may also like
Manufacturing
Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference
By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence
Manufacturing
Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration
CRDMO successfully scaled and transferred Renaissance Pharma’s lead candidate, Daretabart a humanised monoclonal antibody targeting GD2 for high-risk neuroblastoma, in just 9 months
Manufacturing
Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe
After a double-digit million euro investment and less than 1.5 years of construction, SCHOTT Pharma opens new manufacturing site in Jagodina, Serbia. Production capacity to meet European market demand for pharmaceutical ampoules. Facility brings around 180 new jobs to the region
Manufacturing
Bruker announces major strides in 4D proteomics performance, further advances In intact and top-down functional proteoform analysis, and innovations in hybrid qual/quant 4D metabolomics
All to enable deeper insights into disease biology. Bruker Also Launches Two Novel Mass Spectrometry Systems for Unique Applications in Energy Industry Research, and in Semiconductor Manufacturing